4//SEC Filing
BRINKERHOFF WILLIAM F 4
Accession 0001209191-04-008020
CIK 0001066745other
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 9:35 PM ET
Size
9.6 KB
Accession
0001209191-04-008020
Insider Transaction Report
Form 4
BRINKERHOFF WILLIAM F
VP Business Development
Transactions
- Exercise/Conversion
Common Stock
2004-02-05+19,606→ 20,994 total - Disposition from Tender
Common Stock
2004-02-05$35.00/sh−20,994$734,790→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2004-02-05−19,606→ 95,394 total→ Common Stock (19,606 underlying)
Footnotes (5)
- [F1]The price for the acquisition of these shares range from $4.80 per share to $6.75 per share.
- [F2]Disposed of pursuant to an Agreement and Plan of Merger dated December 19, 2003, as amended on January 16, 2004, by and among Esperion Therapeutics, Inc., Enzo Aquisition Corp., and Pfizer Inc., in exchange for a cash payment representing the tender offer price of $35.00 per common share.
- [F3]The options vest in sixteen cumulative quarterly installments beginning on the end of each three month period from the date of grant.
- [F4]The expiration dates of these options range from March 14, 2012 to February 6, 2013.
- [F5]Per SEC Rules for this transaction, this field is not required.
Documents
Issuer
ESPERION THERAPEUTICS INC/MI
CIK 0001066745
Entity typeother
Related Parties
1- filerCIK 0001242618
Filing Metadata
- Form type
- 4
- Filed
- Feb 8, 7:00 PM ET
- Accepted
- Feb 9, 9:35 PM ET
- Size
- 9.6 KB